Allspring Global Investments Holdings LLC Cuts Position in HealthEquity, Inc. (NASDAQ:HQY)

Allspring Global Investments Holdings LLC reduced its stake in shares of HealthEquity, Inc. (NASDAQ:HQY) by 8.3% in the fourth quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The fund owned 951,235 shares of the company’s stock after selling 86,545 shares during the quarter. Allspring Global Investments Holdings LLC owned approximately 1.10% of HealthEquity worth $92,079,000 as of its most recent SEC filing.

A number of other institutional investors also recently added to or reduced their stakes in the stock. Louisiana State Employees Retirement System lifted its position in shares of HealthEquity by 0.4% during the fourth quarter. Louisiana State Employees Retirement System now owns 24,200 shares of the company’s stock valued at $2,322,000 after buying an additional 100 shares during the last quarter. Raymond James Trust N.A. raised its stake in shares of HealthEquity by 4.8% during the 3rd quarter. Raymond James Trust N.A. now owns 2,905 shares of the company’s stock worth $238,000 after acquiring an additional 132 shares in the last quarter. UMB Bank n.a. lifted its position in HealthEquity by 65.6% during the fourth quarter. UMB Bank n.a. now owns 414 shares of the company’s stock valued at $40,000 after acquiring an additional 164 shares during the last quarter. Truist Financial Corp lifted its position in HealthEquity by 7.0% during the second quarter. Truist Financial Corp now owns 2,864 shares of the company’s stock valued at $247,000 after acquiring an additional 188 shares during the last quarter. Finally, Nicolet Advisory Services LLC boosted its stake in HealthEquity by 5.8% in the third quarter. Nicolet Advisory Services LLC now owns 4,218 shares of the company’s stock valued at $330,000 after acquiring an additional 233 shares in the last quarter. Institutional investors own 99.55% of the company’s stock.

Wall Street Analyst Weigh In

A number of equities analysts have recently issued reports on HQY shares. JMP Securities increased their price objective on HealthEquity from $105.00 to $107.00 and gave the company a “market outperform” rating in a report on Tuesday, December 10th. BTIG Research increased their price target on HealthEquity from $110.00 to $130.00 and gave the company a “buy” rating in a research note on Thursday, November 14th. The Goldman Sachs Group began coverage on HealthEquity in a research note on Friday, November 15th. They set a “neutral” rating and a $108.00 price target on the stock. Royal Bank of Canada upped their price objective on shares of HealthEquity from $100.00 to $105.00 and gave the company an “outperform” rating in a report on Tuesday, December 10th. Finally, Bank of America lifted their target price on shares of HealthEquity from $100.00 to $120.00 and gave the stock a “buy” rating in a research note on Wednesday, November 13th. One research analyst has rated the stock with a hold rating and thirteen have assigned a buy rating to the company. Based on data from MarketBeat.com, HealthEquity currently has an average rating of “Moderate Buy” and a consensus target price of $110.71.

Insider Activity at HealthEquity

In other HealthEquity news, Director Robert W. Selander sold 8,250 shares of HealthEquity stock in a transaction on Monday, December 9th. The shares were sold at an average price of $101.56, for a total value of $837,870.00. Following the completion of the transaction, the director now owns 66,469 shares of the company’s stock, valued at approximately $6,750,591.64. The trade was a 11.04 % decrease in their ownership of the stock. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is accessible through this link. Also, Director Stuart B. Parker sold 25,000 shares of the stock in a transaction dated Thursday, December 12th. The stock was sold at an average price of $96.72, for a total transaction of $2,418,000.00. Following the sale, the director now directly owns 19,061 shares in the company, valued at approximately $1,843,579.92. The trade was a 56.74 % decrease in their ownership of the stock. The disclosure for this sale can be found here. Over the last ninety days, insiders sold 39,000 shares of company stock worth $3,895,788. 2.20% of the stock is owned by corporate insiders.

HealthEquity Stock Up 1.8 %

NASDAQ:HQY opened at $114.51 on Thursday. The firm has a market capitalization of $9.92 billion, a P/E ratio of 105.06, a PEG ratio of 1.61 and a beta of 0.55. The company’s fifty day moving average price is $101.63 and its 200-day moving average price is $90.37. HealthEquity, Inc. has a 1-year low of $65.01 and a 1-year high of $114.69. The company has a debt-to-equity ratio of 0.51, a current ratio of 3.20 and a quick ratio of 3.20.

HealthEquity (NASDAQ:HQY) last announced its quarterly earnings results on Monday, December 9th. The company reported $0.59 earnings per share for the quarter, missing the consensus estimate of $0.71 by ($0.12). HealthEquity had a return on equity of 9.70% and a net margin of 8.41%. During the same period last year, the company earned $0.40 EPS. As a group, equities research analysts anticipate that HealthEquity, Inc. will post 2.32 EPS for the current year.

HealthEquity Company Profile

HealthEquity, Inc provides technology-enabled services platforms to consumers and employers in the United States. The company offers cloud-based platforms for individuals to make health saving and spending decisions, pay healthcare bills, receive personalized benefit information, earn wellness incentives, grow their savings, and make investment choices; and health savings accounts.